Cargando…
Eosinophils depletion therapy for severe asthma management following favorable response to mepolizumab
We described three severe asthmatics whose asthma symptoms were rapidly improved by benralizumab following favorable response to mepolizumab. Benralizumab-induced eosinophil depletion contributed to clinical improvement of severe asthma after mepolizumab-induced eosinophil reduction; thus, prior fav...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630060/ https://www.ncbi.nlm.nih.gov/pubmed/31341763 http://dx.doi.org/10.1016/j.rmcr.2019.100899 |